NCT03674606View on ClinicalTrials.gov

Trial of Early Screening Test for Pre-eclampsia and Growth Restriction

PHASE4CompletedINTERVENTIONAL
Enrollment

546

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

April 13, 2016

Study Completion Date

April 13, 2016

Conditions
Pre-EclampsiaPlacenta DiseasesEclampsia PreeclampsiaFetal Growth RetardationFoetal Growth Restriction
Interventions
DRUG

Low dose aspirin

One 75 mg aspirin dose taken daily

Trial Locations (2)

Unknown

National Maternity Hospital, Dublin

Rotunda Hospital, Dublin

All Listed Sponsors
collaborator

Perinatal Ireland

OTHER

collaborator

National Maternity Hospital, Ireland

OTHER

collaborator

Royal College of Surgeons, Ireland

OTHER

lead

University College Dublin

OTHER

NCT03674606 - Trial of Early Screening Test for Pre-eclampsia and Growth Restriction | Biotech Hunter | Biotech Hunter